Van der Heijde D, et al. Ixekizumab Significantly Improves Signs, Symptoms, and Spinal Inflammation of Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial. ACR 2018, abstract 1864.
Kosteneffectiviteit van interventies tegen vermoeidheid bij reumatische aandoeningen
jul 2023 | RA, SLE, Spondyloartritis